Literature DB >> 20555096

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management.

M Mandalà1, A Falanga, F Roila.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20555096     DOI： 10.1093/annonc/mdq199

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  18 in total

Review 1.  The role of direct oral anticoagulants in cancer-related venous thromboembolism: a perspective beyond the guidelines.

Authors:  Cristhiam M Rojas-Hernandez
Journal:  Support Care Cancer       Date:  2017-11-29       Impact factor: 3.603

2.  Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial.

Authors:  Myra F Barginear; Richard J Gralla; Thomas P Bradley; Syed S Ali; Iuliana Shapira; Craig Greben; Nanette Nier-Shoulson; Meredith Akerman; Martin Lesser; Daniel R Budman
Journal:  Support Care Cancer       Date:  2012-03-16       Impact factor: 3.603

3.  Approach to venous thromboembolism in the cancer patient.

Authors:  Andrea Piccioli; Paolo Prandoni
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-04

4.  Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study.

Authors:  Patrizia Ferroni; Francesca Martini; Ilaria Portarena; Italia Grenga; Silvia Riondino; Francesca La Farina; Anastasia Laudisi; Fiorella Guadagni; Mario Roselli
Journal:  Support Care Cancer       Date:  2012-02-10       Impact factor: 3.603

5.  CUSHING'S SYNDROME, A RISK FACTOR FOR VENOUS THROMBOEMBOLISM IS A CANDIDATE FOR GUIDELINES.

Authors:  G Koraćević; M Stojanović; S Petrović; D Simić; D Sakač; M Vlajković; M Stevic; M Kocić; M Đorđević; M Koraćević
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

6.  Salvage surgery for primary lung cancer complicated with Trousseau's syndrome after chemotherapy: a case report.

Authors:  Toshinari Ema; Hiroshi Neyatani; Yasutaka Mochizuka; Kazuyo Yasuda; Saki Yamamoto; Shuhei Iizuka; Kazuhito Funai; Norihiko Shiiya
Journal:  AME Case Rep       Date:  2020-01-20

7.  Cardiovascular oncology: a new discipline inside internal medicine?

Authors:  Domenico Prisco; Mario Milco D'Elios; Caterina Cenci; Lucia Ciucciarelli; Carlo Tamburini
Journal:  Intern Emerg Med       Date:  2014-03-19       Impact factor: 3.397

8.  Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY.

Authors:  Sylvia Haas; Sebastian M Schellong; Ulrich Tebbe; Horst-Eberhard Gerlach; Rupert Bauersachs; Nima Melzer; Claudia Abletshauser; Christian Sieder; Peter Bramlage; Hanno Riess
Journal:  BMC Cancer       Date:  2011-07-26       Impact factor: 4.430

9.  Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival.

Authors:  Anna Falanga; Alfonso Vignoli; Erika Diani; Marina Marchetti
Journal:  Patient Relat Outcome Meas       Date:  2011-11-23

10.  A prospective study on the incidence of postoperative venous thromboembolism in Korean gastric cancer patients: an inquiry into the application of Western guidelines to Asian cancer patients.

Authors:  Jin Won Kim; Eun Ju Chun; Sang Il Choi; Do Joong Park; Hyung-Ho Kim; Soo-Mee Bang; Min Jeong Kim; Ju-Hee Lee; Moon-Soo Lee; Jeong-Ok Lee; Yu Jung Kim; Jee Hyun Kim; Jong Seok Lee; Keun-Wook Lee
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.